Clinical-Instrumental Study To Evaluate And Compare The Efficacy And Tolerability Of Two Emollients Products In Atopic Dermatitis

Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with erythema, scaly and oozing plaques, and severe pruritus which has an important impact on quality of life and quality of sleep. It is divided into 2 chronic phases : flare-up and remission period. Signs and symptoms of AD are associated with a compromised immune system, a defective skin barrier, a cutaneous dysbiosis and overall inflammatory status. The aim of the study is to evaluate and compare the efficacy and tolerability of two face and body cream products, new emollient versus placebo, in used over the course of 5 weeks as a replacement of usual or any emollient by female and male subjects with atopic dermatitis. This is an interventional, single-center, double-blind, randomized and comparative study.

NCT Number	NCT06930365
Lead Sponsor	NAOS Les Laboratoires
Conditions	Atopic Dermatitis, Eczema
Enrollment	64 participants
Start Date	2024-12-09
Primary Completion	2025-05-16 (estimated)
Study Completion	2025-07-18 (estimated)
Updated on ClinicalTrials.gov	2025-04-16